Danone Nutricia announces the launch of Fortimel PlantBased, its first 100% plant-based oral nutritional supplement, developed for the nutritional management of patients who require a higher energy and protein intake. This innovation reinforces the brand's commitment to promoting science-based nutrition that is more inclusive and aligned with new food trends.
Available in Pineapple-Coconut and Cappuccino flavors, Fortimel PlantBased Protein 2 Kcal combines 20 grams of plant-based protein, derived from soy and peas, with 400 kcal per bottle, offering a complete, high-calorie, and high-protein nutritional profile.
It is lactose-free and gluten-free, suitable for vegans, and has Halal certification, making it a safe and effective option for patients with dietary restrictions and specific ethical preferences.
“ Fortimel PlantBased represents a significant evolution in clinical nutrition. It combines scientific rigor and nutritional innovation to offer a complete, effective solution adapted to the evolving needs of patients ,” says Paulo Santos, Head of Danone Nutricia Portugal. “ With this launch, we continue to innovate and respond to real clinical needs, without compromising the dietary preferences and individual values of each person ,” he adds.
New formula for improved adhesion and tolerance.
It is intended for the nutritional management of people with increased energy and protein needs, including cancer patients, people with digestive pathologies, the elderly, vegetarian or vegan patients, and also individuals with digestibility problems, lactose intolerance or allergy to cow's milk protein. It is also a suitable alternative for patients who have difficulty adhering to conventionally flavored oral nutritional supplements.
The new Fortimel Plant-Based formula was developed based on scientific evidence, and in this sense, clinical studies have demonstrated high tolerance and adherence to this product, with significant improvements in energy and protein intake, and an average increase in body weight of 0,9 kg after four weeks of use. These results confirm the effectiveness and good acceptance of the product among patients and healthcare professionals.
